Overview
MiMedx Group, Inc. ("MiMedx Group") is an integrated developer, manufacturer and marketer of patent protected biomaterial-based products. The company is successfully emerging from a development-focused start-up phase into a fully integrated operating company with expertise to capitalize on its science and technology and its capacity to generate sales growth and profitability.
Our platform technologies, AmnioFix®, EpiFix®, HydroFix® and CollaFix®, have such a vast number of potential applications in treating traumatized tissue and structures that it is too difficult to accurately quantify. MiMedx Group is focused on commercializing multiple applications of all three technologies. In parallel, we are seeking strategic relationships to more rapidly commercialize our technologies.
MiMedx Conference Presentations.
Click to listen to Needham Growth Conference Jan. 10, 2012
Click to watch Noble Financial Equity Conference Jan. 17, 2012
Click to listen to Canaccord Genuity Musculoskeletal Conference Feb 7, 2012
Click here to view the slide deck for the Canaccord audio.
